Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 33Recurrence 8Lymphoma 7Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Leukemia 3Waldenstrom Macroglobulinemia 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Hematologic Neoplasms 2Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lung Neoplasms 1Leukemia, Prolymphocytic 1Leukemia, Plasma Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Failure, Chronic 1

Interventions

fludarabine phosphate 7Cyclophosphamide 7Rituximab 6Cyclosporine 4Pharmacogenomic Testing 3Filgrastim 3alvocidib 2Whole-Body Irradiation 2RFB4(dsFv)-PE38 recombinant immunotoxin 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Lenalidomide 2Doxorubicin 2Cord Blood Stem Cell Transplantation 2Carboplatin 2Bortezomib 2Amifostine 2venetoclax 1tanespimycin 1selinexor 1sargramostim 1pyroxamide 1obinutuzumab 1obatoclax 1nelarabine 1motexafin gadolinium 1laromustine 1immunotoxin HA22 1ibrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Prolymphocytic × carfilzomib × Clear all
NCT01212380 2016-05-09

Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
21 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡